Financials Extendicare Inc.

Equities

EXE

CA30224T8639

Healthcare Facilities & Services

Market Closed - Toronto S.E. 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
7.3 CAD 0.00% Intraday chart for Extendicare Inc. +0.55% +0.27%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 752.2 594.5 653.8 561 605.6 608.7 - -
Enterprise Value (EV) 1 752.2 594.5 653.8 561 605.6 608.7 608.7 608.7
P/E ratio - - - - - - - -
Yield 5.69% 7.23% 6.58% 7.32% 6.59% 6.58% 11.1% 34%
Capitalization / Revenue 0.66 x 0.51 x 0.54 x 0.46 x 0.46 x 0.45 x 0.44 x 0.46 x
EV / Revenue 0.66 x 0.51 x 0.54 x 0.46 x 0.46 x 0.45 x 0.44 x 0.46 x
EV / EBITDA 8.26 x 4.47 x 6.96 x 9.76 x 6.36 x 6.42 x 6.09 x 6.08 x
EV / FCF 62.7 x 6.74 x -107 x -47.4 x -8.4 x -203 x - -
FCF Yield 1.6% 14.8% -0.93% -2.11% -11.9% -0.49% - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 89,123 89,539 89,562 85,514 83,191 83,384 - -
Reference price 2 8.440 6.640 7.300 6.560 7.280 7.300 7.300 7.300
Announcement Date 2/27/20 2/25/21 2/24/22 3/2/23 3/7/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,132 1,158 1,217 1,222 1,305 1,346 1,368 1,318
EBITDA 1 91.11 133.1 93.92 57.45 95.19 94.87 99.9 100.1
EBIT - - - - - - - -
Operating Margin - - - - - - - -
Earnings before Tax (EBT) - - - - - - - -
Net income - - - - - - - -
Net margin - - - - - - - -
EPS - - - - - - - -
Free Cash Flow 1 12 88.16 -6.099 -11.83 -72.14 -3 - -
FCF margin 1.06% 7.61% -0.5% -0.97% -5.53% -0.22% - -
FCF Conversion (EBITDA) 13.17% 66.22% - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 0.4800 0.4800 0.4800 0.4800 0.4800 0.4800 0.8133 2.480
Announcement Date 2/27/20 2/25/21 2/24/22 3/2/23 3/7/24 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 310.1 319.4 305.7 296.6 308.9 310.4 324.7 307.5 322.5 350.2 323 318.1 326 339
EBITDA 19.34 27.73 19.56 17.1 10.03 9.16 - - 20.77 - - - - -
EBIT - - - - - - - - - - - - - -
Operating Margin - - - - - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - - - - - -
Net income - - - - - - - - - - - - - -
Net margin - - - - - - - - - - - - - -
EPS - - - - - - - - - - - - - -
Dividend per Share 0.1200 0.1200 - - - - - - - - - - - -
Announcement Date 11/4/21 2/24/22 5/12/22 8/9/22 11/10/22 3/2/23 5/4/23 8/10/23 11/9/23 3/7/24 - - - -
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 12 88.2 -6.1 -11.8 -72.1 -3 - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 2/27/20 2/25/21 2/24/22 3/2/23 3/7/24 - - -
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
7.3 CAD
Average target price
8 CAD
Spread / Average Target
+9.59%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. EXE Stock
  4. Financials Extendicare Inc.